Islet transplantation in genetically determined diabetes

Area of Science:

• Endocrinology
• Transplantation Immunology
• Metabolic Diseases

Background:

• Pancreatic islet transplantation is a potential therapy for diabetes, successfully reversing hyperglycemia in chemically induced and some genetic models.
• Graft rejection and the underlying disease mechanisms present significant challenges for widespread clinical application.
• The efficacy of islet transplantation across different diabetes etiologies remains incompletely understood.

Purpose of the Study:

• To investigate the efficacy of pancreatic islet transplantation in various mouse models of diabetes, including chemically induced and genetically determined forms.
• To determine if the metabolic defect in specific genetic diabetes models resides within the pancreatic islets themselves.
• To assess the potential of islet transplantation as a universal treatment for diabetes, considering different underlying causes.

Main Methods:

• Induction of hyperglycemia in mice using beta cell toxins (streptozotocin) or genetic models (db/db, ob/ob, NZO).
• Transplantation of syngeneic, allogeneic (xenogeneic rat islets with immunosuppression), and coisogenic islets into diabetic recipients.
• Evaluation of recipient glycemic control and islet function post-transplantation.

Main Results:

• Syngeneic islet transplantation permanently cured streptozotocin-induced diabetic mice.
• Immunosuppressed recipients of xenogeneic rat islets achieved temporary normoglycemia (six weeks).
• Islets from db/db mice functioned normally in non-diabetic hosts, indicating the defect is extranatomic; however, islets were ineffective in db/db recipients.

Conclusions:

• Pancreatic islet transplantation can be curative for certain types of diabetes, such as streptozotocin-induced hyperglycemia.
• The metabolic defect in db/db mice, analogous to human maturity-onset diabetes, is not intrinsic to their islets.
• Islet transplantation's success is highly dependent on the specific diabetes etiology, suggesting it may not be a universal cure for all forms of diabetes.